Dr Jonathon Preston

Healthcare policy can shape whether people with attention-deficit/hyperactivity disorder (ADHD) are able to obtain an evaluation, continue treatment, and receive support at school or work. Changes associated with the Trump administration—and the possibility of further changes under shifting political leadership—have therefore raised important questions about affordability, insurance rules, Medicaid, and access to mental healthcare. The … Read more

Political leadership can influence much more than formal health policy. The officials selected to oversee public health, research, education, and healthcare access also help shape the language used to discuss medical and mental health conditions. That makes presidential health appointments relevant to the public conversation about attention-deficit/hyperactivity disorder (ADHD). Whether these appointments reduce or reinforce … Read more

Changes in federal healthcare leadership can influence the environment in which ADHD education, research, and support programs operate. Appointees at agencies connected to health, mental health, and childhood development may affect funding priorities, guidance, public messaging, and coordination between healthcare and education systems. These effects are not automatic. Schools, state agencies, healthcare providers, and community … Read more

Changes in political leadership can influence which health issues receive attention, how research priorities are described, and where public resources are directed. That raises an important question for the ADHD community: could appointments made during a Trump administration alter the course of ADHD research funding? The answer cannot be determined from appointments alone. Research funding … Read more

Government health officials can influence ADHD care in ways that reach far beyond a single policy announcement. Their decisions may affect research priorities, public messaging, insurance access, medication availability, school support, and the willingness of families to seek help. That makes the approach taken by officials associated with the Trump administration an important subject for … Read more

Changes in federal health leadership can shape the environment in which ADHD is diagnosed, treated, researched, and supported. Political appointments do not determine an individual’s care directly, but they can influence agency priorities, research funding, public guidance, insurance policy, education programs, and access to behavioral health services. For people with ADHD and their families, the … Read more

Federal health appointments rarely change ADHD diagnosis or treatment overnight. Their influence is usually indirect: senior officials help set agency priorities, shape funding decisions, oversee regulations, and influence how mental-health services are discussed and supported. During the Trump administration discussed here, those decisions raised questions about access to ADHD evaluations, medication, behavioral care, research, and … Read more

Access to ADHD medication is influenced by more than a clinician’s decision to prescribe it. Federal health policy, state rules, insurance coverage, pharmacy practices, and the availability of mental-health professionals all play a role. For that reason, presidential health appointments can matter—but their effect is usually indirect and develops over time. Health officials appointed by … Read more